OSL partners with BolusCare to bring mouldable radiotherapy bolus solution to the UK and Ireland
Oncology Systems Limited (OSL) has entered into a distribution partnership with BolusCare UG, making OSL the official distributor of BolusCare UG’s mouldable radiotherapy bolus solution across the UK and Ireland.
The partnership will support radiotherapy departments seeking patient-specific, workflow-oriented bolus solutions designed to improve fit, reproducibility and ease of use in clinical practice. BolusCare is a two-component device that can be moulded directly to a patient’s anatomy, aiming to reduce air gaps between the bolus and the skin and support more consistent positioning throughout a course of treatment.
OSL MD Alice Pavey said: “This is an exciting addition to our radiotherapy portfolio and we look forward to introducing this innovative bolus solution to more radiotherapy centres and their patients.”
BolusCare UG CEO Bastian Hollmann added: “Having worked with the OSL team in the past, I have always appreciated their professionalism, strong reputation and deep expertise in radiotherapy. It is great to continue this relationship with BolusCare. We are con dent that OSL’s experienced team will play a key role in introducing our patient-speci fic bolus solution to radiotherapy centres across the UK and Ireland, helping clinicians improve treatment workflows and patient care.”
Picture: BolusCare provides an alternative to conventional sheet bolus and more resource-intensive customised solutions.
Read this report on page 9 of the September 2026 issue of RAD Magazine.
